Results 91 to 100 of about 5,496,574 (258)
The Imperative to Develop Dedicated Stroke Centers
OLDER PRACTITIONERS (INCLUDING ONE OF THE AUthors of this Editorial) will recall the days when patients with stroke were either treated at home or admitted to the hospital for compassionate observation. Neurologists made efforts to localize lesions and confirm functional areas of the brain and brainstem and described many vascular syndromes.
Barnett, H, Buchan, A
openaire +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
A summary of primary stroke center policy in the United States [PDF]
Stroke is a leading cause of death in the United States. Much is known about how to treat stroke victims swiftly and effectively, yet the accessibility of health care facilities with the resources and processes to care for acute stroke patients varies ...
National Center for Chronic Disease Prevention and Health Promotion (U.S.) Division for Heart Disease and Stroke Prevention.
core
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro +6 more
wiley +1 more source
Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon +5 more
wiley +1 more source
Antiplatelet Therapy May Be Insufficient to Prevent Stroke Recurrence Before Percutaneous Patent Foramen Ovale Closure [PDF]
Hiroyuki Kawano +9 more
doaj +1 more source
Letter from Aring, Charles D. to Sabin, Albert B. dated 1965-08-16.Sabin Collection Fair Use PolicyIncludes "Summary of the Prospects for a Regional Center for Heart Disease, Cancer and Stroke Based at the University of Cincinnati College of Medicine.
Aring, Charles D., 1904-
core +1 more source
ABSTRACT Objective Digital technologies hold promise for transforming healthcare by enhancing personalized treatments and offer valuable opportunities to improve patient care. Here, we evaluated several novel, self‐administered, home‐based, digital endpoints for their association with corresponding conventional standard clinical measures (primary) in ...
Arne Mueller +14 more
wiley +1 more source
Antioxidant status in acute stroke patients and patients at stroke risk [PDF]
Background and Purpose: Antioxidant enzymes like copper/ zinc superoxide dismutase (SOD), catalase and gluthatione peroxidase (GSHPx) are part of intracellular protection mechanisms to overcome oxidative stress and are known to be activated in vascular ...
Haberl, R. L. +9 more
core +1 more source

